Literature DB >> 3725423

A comparison of selective media for the isolation of anaerobic bacteria from clinical material.

J Downes, L Stern, J H Andrew.   

Abstract

Clinical specimens submitted for anaerobic culture to a Melbourne teaching hospital microbiology laboratory were plated onto 3 types of selective media, to determine which would allow the optimal recovery of anaerobic organisms. The 3 media employed were kanamycin agar (KA), neomycin agar (NA) and nalidixic acid-Tween 80 agar (NAT). The highest isolation rate was achieved on NAT, 89% of the total of all anaerobes isolated being recovered on this medium. A recovery rate of 69% was achieved using NA, while use of KA allowed the isolation of only 56% of all strains. The major difference between 3 media was in the recovery of anaerobic Gram-positive cocci, which accounted for 40% of the total isolates on NAT, 25% on NA, and only 11% on KA. The NAT was also more successful in the isolation of Fusobacterium and Veillonella species. The NAT medium failed, however, to recover Clostridium spp. that were isolated on both NA and KA. There was no significant difference between the 3 media in regard to the recovery of Bacteroides spp.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3725423     DOI: 10.3109/00313028609090842

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  2 in total

1.  Enhancement of antimicrobial activity against pseudomonas aeruginosa by coadministration of G10KHc and tobramycin.

Authors:  Randal Eckert; Keith M Brady; E Peter Greenberg; Fengxia Qi; Daniel K Yarbrough; Jian He; Ian McHardy; Maxwell H Anderson; Wenyuan Shi
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

2.  Comparison of different medium bases for the semiquantitative isolation of anaerobes from vaginal secretions.

Authors:  A Sheppard; C Cammarata; D H Martin
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.